Thu, December 7, 2023

Andrew Tsai Upgraded (VTGN) to Strong Buy and Increased Target to $15 on, Dec 7th, 2023

Andrew Tsai of Jefferies, Upgraded "Vistagen Therapeutics, Inc." (VTGN) to Strong Buy and Increased Target from $0.2 to $15 on, Dec 7th, 2023.

Andrew has made no other calls on VTGN in the last 4 months.



There are 2 other peers that have a rating on VTGN. Out of the 2 peers that are also analyzing VTGN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Paul Matteis of "Stifel" Initiated at Strong Buy and Held Target at $12 on, Tuesday, November 14th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy and Held Target at $30 on, Tuesday, September 5th, 2023